AA
Addison Advisors Portfolio holdings
AUM
$401M
1-Year Return
12.64%
This Quarter Return
-3.71%
1 Year Return
+12.64%
3 Year Return
+45.67%
5 Year Return
–
10 Year Return
–
AUM
$183M
AUM Growth
+$21.2M
(+13%)
Cap. Flow
+$28.3M
Cap. Flow
% of AUM
15.49%
Top 10 Holdings %
Top 10 Hldgs %
32.52%
Holding
813
New
82
Increased
289
Reduced
63
Closed
39
Top Buys
| 1 |
WisdomTree Floating Rate Treasury Fund
USFR
|
$2.44M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$1.42M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$1.08M |
| 4 |
FlexShares Quality Dividend Index Fund
QDF
|
$939K |
| 5 |
Apple
AAPL
|
$811K |
Top Sells
Sector Composition
| 1 | Technology | 9.67% |
| 2 | Financials | 4.98% |
| 3 | Healthcare | 4.9% |
| 4 | Industrials | 3.18% |
| 5 | Consumer Staples | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Shell
SHEL
$208B
| $135K | 0.07% |
+2,452
| New | +$135K |
|
177
Air Products & Chemicals
APD
$64.5B
| $134K | 0.07% |
535
+283
| +112% | +$70.9K |
|
178
Invesco International Dividend Achievers ETF
PID
$863M
| $133K | 0.07% |
6,770
| – | – |
|
|
EFT
179
Eaton Vance Floating-Rate Income Trust
EFT
$319M
| $131K | 0.07% |
9,935
| – | – |
|
180
Texas Instruments
TXN
$171B
| $131K | 0.07% |
714
+132
| +23% | +$24.2K |
|
181
RELX
RELX
$85.9B
| $130K | 0.07% |
4,166
+379
| +10% | +$11.8K |
|
182
SAP
SAP
$313B
| $130K | 0.07% |
1,171
+1,114
| +1,954% | +$124K |
|
183
Amgen
AMGN
$153B
| $128K | 0.07% |
531
-42
| -7% | -$10.1K |
|
184
Nuveen ESG Small-Cap ETF
NUSC
$1.21B
| $128K | 0.07% |
3,221
+2,542
| +374% | +$101K |
|
185
Meta Platforms (Facebook)
META
$1.89T
| $127K | 0.07% |
569
+253
| +80% | +$56.5K |
|
186
Aflac
AFL
$57.2B
| $126K | 0.07% |
1,960
+666
| +51% | +$42.8K |
|
187
Salesforce
CRM
$239B
| $126K | 0.07% |
592
+518
| +700% | +$110K |
|
188
General Motors
GM
$55.5B
| $126K | 0.07% |
2,881
+907
| +46% | +$39.7K |
|
189
McCormick & Company Non-Voting
MKC
$19B
| $126K | 0.07% |
1,260
-16
| -1% | -$1.6K |
|
190
Southern Company
SO
$101B
| $126K | 0.07% |
1,737
+444
| +34% | +$32.2K |
|
191
Novartis
NVS
$251B
| $124K | 0.07% |
1,415
+884
| +166% | +$77.5K |
|
192
Trane Technologies
TT
$92.1B
| $124K | 0.07% |
809
| – | – |
|
193
iShares Preferred and Income Securities ETF
PFF
$14.5B
| $123K | 0.07% |
3,365
+2,247
| +201% | +$82.1K |
|
194
Thomson Reuters
TRI
$78.7B
| $123K | 0.07% |
+1,090
| New | +$123K |
|
195
SPDR S&P Biotech ETF
XBI
$5.39B
| $121K | 0.07% |
1,342
+200
| +18% | +$18K |
|
196
Bio-Rad Laboratories Class A
BIO
$8B
| $113K | 0.06% |
201
| – | – |
|
197
Crown Castle
CCI
$41.9B
| $112K | 0.06% |
605
| – | – |
|
198
Moody's
MCO
$89.5B
| $112K | 0.06% |
332
+329
| +10,967% | +$111K |
|
199
United Parcel Service
UPS
$72.1B
| $111K | 0.06% |
518
+474
| +1,077% | +$102K |
|
200
Lam Research
LRCX
$130B
| $108K | 0.06% |
2,000
-10
| -0.5% | -$540 |
|